Trial Information
TENACITY: A Phase 2, Multicenter, Open-label, Single-arm Study of AL101 Monotherapy in Patients with Notch-activated Triple Negative Breast Cancer
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724